Priyanka Raheja: Sharing the Final Analysis From the Roctavian Phase 1/2 Study
Priyanka Raheja, Director at The Royal London Hospital Haemophilia Comprehensive Care Centre, shared EAHAD’s post on LinkedIn about a recent article she and her colleagues co-authored, published in Haemophilia Journal, adding:
“Sharing the final analysis from the Roctavian phase 1/2 study.
Despite the sad news of market withdrawal, the long term follow up of the first people who participated in this trial continues to provide important learnings.”
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
“Check the article recently published on our official journal on ‘Final Analysis of the Phase 1/2 Trial of Valoctocogene Roxaparvovec for Severe Haemophilia A’.
Take a closer look at the data on the Haemophilia Journal.”
Title: Final Analysis of the Phase 1/2 Trial of Valoctocogene Roxaparvovec for Severe Haemophilia A
Authors: Priyanka Raheja, Savita Rangarajan, Will Lester, Bella Madan, Glenn F. Pierce, Emily Symington, Carolyn Millar, Dane Osmond, Mingjin Li, Konstantia-Maria Chavele
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 4, 2026, 16:17Nada Fahd: Immune Thrombocytopenia (ITP) – Outpatient vs Inpatient Management
-
Jun 4, 2026, 16:16Saoud Hassan: Hemostasis and Blood Coagulation Pathway – Simplified
-
Jun 4, 2026, 16:15Farooq Khan: Vacuuming Blood Clots in Seconds
-
Jun 4, 2026, 16:14Kayla Garrett: Confirming Or Excluding APS Relies On Accurate Lupus Anticoagulant Testing
-
Jun 4, 2026, 16:14Scott Colton: Exploring the Key Differences Between Anticoagulant and Antiplatelet Medications
-
Jun 4, 2026, 16:13Wolfgang Miesbach: Is Bone Health a Silent Comorbidity In Haemophilia and VWD?
-
Jun 4, 2026, 15:35Carolina La Mura: Insights from the LATAM Hemophilia Forum 2026
-
Jun 4, 2026, 15:25Heba Youssef: Anticoagulation Bridging – A Clinical Summary Every Practitioner Should Know
-
Jun 4, 2026, 15:10Dipanjana Datta: Genetic Spectrum of Hemophilia and Carrier Screening in Families of Persons with Hemophilia